Ibuprofen Active Pharmaceutical Ingredient (Api) Market Analysis Asia, North America, Europe, Rest of World (ROW) - US, India, China, Germany, UK - Size and Forecast 2024-2028

Ibuprofen API Market Forecast 2024-2028

The ibuprofen active pharmaceutical ingredient market is estimated to grow by USD 26.3 million at a CAGR of 2.08% between 2023 and 2028. The pharmaceutical industry is experiencing significant shifts due to several key factors. The global population is aging, leading to an increased demand for healthcare solutions, particularly in the geriatric sector. In response, there is a growing focus on Advanced Product and Process Technology (APIT) in developing countries to meet this demand. This includes the manufacturing of APIs, or Active Pharmaceutical Ingredients, which are essential components of medicines. With the rise in both pharmaceutical and biopharmaceutical production, there is a pressing need for efficient, cost-effective, and high-quality API manufacturing solutions. This trend is driving innovation and investment in this sector, particularly in regions such as Asia and Latin America, where labor costs are lower and regulatory frameworks are evolving to support the growth of the industry.

What will be the size of the Ibuprofen API Market During the Forecast Period?

To learn more about this report, Download Report Sample

Market Dynamics

The market forecasting is driven by the increasing prevalence of chronic diseases such as rheumatoid arthritis and migraine in emerging economies. Ibuprofen, a non-steroidal anti-inflammatory drug (NSAID), is widely used to treat pain and inflammation. The pharmaceutical and biochemical organizations are focusing on producing ibuprofen in various forms like tablets, capsules, and syrups to cater to diverse patient needs. Geriatric patients are a significant consumer group due to the higher prevalence of chronic diseases in this population. However, the use of ibuprofen is not without risks, including gastrointestinal bleeding and kidney damage. The production of ibuprofen involves synthetic routes, which have environmental drawbacks. Manufacturers are adhering to production guidelines to minimize the risks and costs. The use of biopharmaceutical companies' advanced technologies like bioinformatics, high-throughput methods, and combinatorial chemistry is helping in the production of ibuprofen. The market for ibuprofen API is expected to grow due to the increasing demand for ibuprofen in the treatment of menstrual discomfort, dysmenorrhea, and other conditions. However, the high manufacturing costs remain a challenge for the market growth.

Key Market Driver

The increasing geriatric population is notably driving the market. The risk of contracting chronic illness increases with age, which, in turn, fuels the demand for ibuprofen APIs. According to the Centers for Disease Control and Prevention (CDC), the number of US adults aged 65 years and above is expected to reach approximately 71 million. This will increase the diagnosis of age-related diseases in the susceptible patient population, which will fuel the adoption of different therapeutics.

The growth in the geriatric population increases the burden on the national health system. As a result, healthcare financing has become a critical policy issue. Therefore, national healthcare regulatory bodies promote the use of generic drugs to reduce the impact of economic burden. This, in turn, increases the penetration of generic drug manufacturers in the US and Europe. Such manufacturers outsource raw materials from ibuprofen API manufacturers to provide cost-effective therapeutics. This, in turn, will contribute to the global market during the forecast period.

Significant Market Trend

The paradigm shift in API manufacturing is a key trend influencing the market. Many pharmaceutical companies outsource a large share of their research and manufacturing processes to drug manufacturing organizations. Outsourcing is done due to several factors, such as industry trends, the high cost of acquiring new technologies, and the availability of internal capacity. 

Outsourcing the manufacturing of ibuprofen APIs is helpful for small organizations that do not have the internal capacity and financial budget to manufacture ibuprofen APIs in-house. It also saves time invested in manufacturing. Outsourcing of ibuprofen APIs enables innovators and manufacturers to meet development timelines while capitalizing on high efficiency in their supply chain. Therefore, the paradigm shift from captive ibuprofen API manufacturing to contract ibuprofen API manufacturing is anticipated to have a positive impact on the market during the forecast period.

Major Market Challenge

Stringent regulations are challenging the market. Regulatory authorities need to evaluate drug-related data carefully before approval. They examine aspects such as safety, efficacy, pharmacological data, pharmacodynamic effects, and drug interactions. If a drug fails any of these criteria, the applicant may receive a complete response letter (CRL) or face complete rejection from regulatory agencies.

A drug applicant needs to furnish additional data about the drug after receiving a CRL, which may require additional clinical trials and increase the R&D expenditure of the drug. In some cases, drug applicants withdraw their applications and discontinue their drug trials. These factors are expected to hinder the global market during the forecast period.

Key Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their strategies.

Global Market Customer Landscape

Who are the Major Ibuprofen API Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Chemino Pharma Ltd. - The company is engaged in the manufacturing of pharmaceutical products such as active pharmaceutical ingredients, intermediate chemicals, and trading of solvents such as toluene, ISO propyl alcohol, phenol, and ethyl acetate. The key offerings of the company include nonsteroidal ibuprofen anti-inflammatory drugs. 

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

• Arch Pharmalabs Ltd.
• Athos Chemicals Pvt. Ltd.
• Azelis SA
• BASF SE
• Dr. Reddys Laboratories Ltd.
• Granules India Ltd.
• HELM AG
• IOL Chemicals and Pharmaceuticals Ltd.
• Mallinckrodt Plc
• Octavius Pharma Pvt Ltd.
• Piramal Enterprises Ltd.
• Rochem International Inc.
• SI Group Inc.
• Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd.
• Solara Active Pharma Sciences Ltd.

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

Market Segmentation

The market share growth by the pharmaceutical companies segment will be significant during the forecast period. This is one of the most popular products in this segment owing to its wide range of applications, such as easing mild to moderate pain, including toothache, migraine, and menstrual cramps. It is used as an analgesic and antipyretic agent and has anti-inflammatory properties. This is also used in the treatment of various conditions, such as rheumatoid arthritis and osteoarthritis.

Get a glance at the market contribution of various segments Request a PDF Sample

The pharmaceutical companies segment was valued at USD 133.8 million in 2018. Ibuprofen inhibits the production of prostaglandins, which are hormones that cause pain and inflammation. It is a popular choice for the treatment of pain, as it is relatively safe and effective. These factors will drive the growth of the segment during the forecast period.

Key Regions

For more insights on the market share of various regions Request PDF Sample now!

Asia is estimated to contribute 54% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The growth of the market is attributed to factors such as the growing prevalence of migraine, chronic disorders, and other disorders. The manufacturing of pharmaceutical drugs, such as ibuprofen API, is increasing in Asia due to low manufacturing costs in China and India. As a result, the number of production facilities has increased. The increasing geriatric population will also drive the growth of the market in Asia. The geriatric population is more prone to chronic diseases. Hence, the anticipated rise in population is expected to fuel the demand for innovative pain relief. These factors will drive the growth of the market in Asia during the forecast period.

Segment Overview

The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.

• End-user Outlook
  • Pharmaceutical companies
  • Contract manufacturing organizations

• Product Outlook
  • Prescription 
  • Over-the-counter 

• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • ROW
    • Australia
    • Argentina
    • Rest of the world

You may also be interested in:

• Active Pharmaceutical Ingredients (API) Market Analysis Asia, North America, Europe, Rest of World (ROW) - US, Germany, China, India, Japan - Size and Forecast
• Anti-inflammatory Therapeutics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, Canada, China - Size and Forecast 
• Isobutyl Benzene Market Analysis APAC, Europe, North America, Middle East and Africa, South America - US, China, India, Germany, France - Size and Forecast 

Market Analyst Overview

Ibuprofen API, a non-steroidal anti-inflammatory drug (NSAID), is extensively used in various industries, including cosmetics. The demand for ibuprofen in cosmetics is driven by its analgesic and anti-inflammatory properties, making it an ideal ingredient for skincare products. The market for ibuprofen API in cosmetics is witnessing significant growth due to the increasing popularity of specialty products, such as skincare masks and vegan beauty products. Millennials, with their preference for eco-friendly packaging and organic ingredients, are a key consumer demographic driving this trend. Cosmetic Essence Innovations, CoValence Laboratories, and other personal care brands are investing heavily in product innovation and development expenditure to cater to this growing demand. Compliance standards, such as those set by the Personal Care Products Council and the European Commission, are crucial in ensuring the safety and efficacy of cosmetic products containing ibuprofen API. The use of plant-based extracts and biotechnologically derived components in ibuprofen formulations is also gaining popularity, as consumers seek natural and sustainable alternatives. Personal hygiene and male grooming products are other areas where ibuprofen API is finding increasing use. Contract manufacturing plays a vital role in the production of these products, enabling personal care brands to focus on advertising and intellectual property rights while ensuring compliance with regulatory requirements. Unilever and Procter & Gamble Company are some of the major players in the cosmetics industry leveraging ibuprofen API for their product offerings.

Further, the market is a critical segment within the pharmaceutical industry, driven by its analgesic properties and effectiveness in treating joint inflammation like rheumatoid arthritis and autoimmune diseases such as lupus. Manufacturers focus on optimizing the synthetic route and managing production costs to meet the demand from top pharmaceutical producers and healthcare environments worldwide. With a rising elderly population, the demand for NSAIDs like ibuprofen increases, addressing chronic diseases prevalent among geriatric patients. Ibuprofen APIs are commonly found in tablets, capsules, and syrups, widely available on pharmacy shelves globally. As pharmaceutical and biochemical organizations innovate, they navigate regulatory standards set by bodies like the World Health Organization, ensuring safe and effective therapies for conditions ranging from musculoskeletal disorders to migraines and infectious diseases.

Request PDF sample

What are the Key Data Covered in this Market Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
• Precise estimation of the size of the market size and its contribution to the parent market
• Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
• Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
• Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this report to meet your requirements. Get in touch